Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular

Joshua B Feinberg1,2, Emil E Nielsen1,2, Sverre E Kjeldsen3

  • 1Department of Internal Medicine, Cardiology Section, Holbaek Hospital, Holbaek, Denmark.

Insights

Females with new-onset atrial fibrillation (AF) have a higher stroke risk than males, particularly older women. However, stroke risk is similar for males and females with a history of AF.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Clinical Trials

Background:

  • Atrial fibrillation (AF) poses a higher stroke risk in females than males, but the reasons remain unclear.
  • Biological sex differences may contribute to this disparity, warranting further investigation.

Purpose of the Study:

  • To investigate sex-specific differences in stroke risk among patients with hypertension and left ventricular hypertrophy (LVH) and atrial fibrillation (AF).
  • To analyze stroke risk based on new-onset AF versus a history of AF in relation to sex and age.

Main Methods:

  • Utilized data from The Losartan Intervention for Endpoint study, a multicenter randomized clinical trial.
  • Analyzed stroke risk in 9,193 patients with hypertension and LVH, followed for at least four years.
  • Stratified analysis by sex, age, and AF status (new-onset vs. history of AF).

Main Results:

  • Females with new-onset AF showed a trend toward higher stroke risk (HR 1.52) compared to males.
  • This increased risk in females with new-onset AF was more pronounced in older patients (above 64 years).
  • No significant sex difference in stroke risk was observed for patients with a history of AF (HR 0.88).

Conclusions:

  • In patients with hypertension and LVH, new-onset AF confers a higher stroke risk in females than males, particularly in older age groups.
  • Stroke risk is comparable between sexes for patients with a history of AF, increasing with age in both.
  • Sex-specific risk stratification may be important for managing stroke risk in AF patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
33
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
19
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
33
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
50